hemorrhoid. Disease of anus and rectum, unspecified
Conditions
Interventions
Intervention 1: Intervention group: ointment Myrtus communis, topical, every 12 hours for 4 weeks. Intervention 2: Control group: ointment anti-hemorrhoid, quite similar to ointment Myrtus communis, t
Treatment - Drugs
Intervention group: ointment Myrtus communis, topical, every 12 hours for 4 weeks
Control group: ointment anti-hemorrhoid, quite similar to ointment Myrtus communis, topical, every 12 hours for 4 weeks
Sponsors
Vice President of Research Tabriz University Of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Women have given birth for at least 4 weeks and up to 4 months from their delivery, either in the normal way of any cesarean section (including Nully Par and Multipar); women in post delivery period who have been diagnosed their hemorrhoids first and second degree with clinical symptoms and confirmed by the Surgeon General; women between 18-40 years; Women in the postpartum period whose hemorrhoids are not caused by systemic diseases such as hypertension; hemorrhoid symptomsfor at least more than 7 days; The ability to read and write. Exclusion criteria: Use of Systemic steroid Drugs and non-steroidal anti-inflammatory drugs and analgesics and anti-hemorrhoid treatments (for a one month prior to the study) and the use of anticoagulant drugs; require surgical procedure for the treatment of hemorrhoids (a gastroenterologist confirmed by clinical testing and colonoscopy); women with problems such as abscesses, anorectal, fistula, tuberculosis, herpes, varicella, fungal infection (confirmed by clinical trials or colonoscopy); risk of gastrointestinal tract infectious inflammatory diseases or colorectal cancer (as the patient); The previous use of laser or the use of medication felebotonic to treat hemorrhoids a week before the study (as the patient); Delivery with vacuums or forceps and delivery of cesarean section with large ancision; the company in another intervention study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The mean score of the symptoms of hemorrhoids. Timepoint: Before intervention, 1, 2, 4 and 8 weeks after intervention. Method of measurement: (Colo-Rectal Evaluation of Clinical Therapeutics Scale) (CORECTS).;Quality of life score. Timepoint: Before intervention? 4 and 8 weeks after intervention. Method of measurement: The World Health Organization Quality of Life questionnaire of 26 questions (WHOQOL-BREF). | — |
Secondary
| Measure | Time frame |
|---|---|
| The frequency of side events incidence. Timepoint: During 8 weeks after intervention. Method of measurement: The side events check list.;The patients satisfaction of received drug. Timepoint: 4 and 8 weeks after intervention. Method of measurement: The check list of satisfaction of received drug. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKhadijeh Samady
Tabriz University of Medical Sciences
Outcome results
None listed